Projects per year
Personal profile
Headline
PROFESSOR Medicine, Cardiology
Fingerprint
Dive into the research topics where Juan Badimon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 6 Finished
-
Targeting platelets in chronic HIV infection
O'Brien, M. P. & Badimon, J.
National Heart, Lung, and Blood Institute
1/09/15 → 31/08/17
Project: Research
-
ANTITHROMBOTIC EFFECT OF DZ-697B COMPARED TO CLOPIDOGREL
National Center for Research Resources
1/03/07 → 29/02/08
Project: Research
-
Translational Studies of Depression, Platelets, &CAD
National Heart, Lung, and Blood Institute
10/09/02 → 31/08/04
Project: Research
-
-
TISSUE FACTOR, THROMBOSIS AND THE ARTERIAL WALL
Nemerson, Y. Y. R., Coller, B. B., Coller, B., Fallon, J. T., Fuster, V., Harpel, N. P., Chesebro, J. J., Fallon, J. J., Fallon, J. J. T., Badimon, J. J. J., Taubman, M. M. B., Nemerson, Y. R., Harpel, P. P., Taubman, M. B., Fuster, V. V., Nemerson, Y. R., Badimon, J., Chesebro, N. J. & Fallon, N. J.
National Heart, Lung, and Blood Institute
1/03/96 → 31/01/07
Project: Research
-
Consenso latinoamericano para el manejo del riesgo residual cardiometabólico. Consenso realizado por la Academia Latinoamericana de Lipidología y Riesgo Cardiometabólico (ALALIP), con el aval de la Sociedad Interamericana de Cardiología (SIAC), la Sociedad Interamericana de Aterosclerosis (IAS) y el Colegio Panamericano de Endotelio (PACE)
Translated title of the contribution :Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE) Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Effects of electret coating technology on coronary stent thrombogenicity
Zafar, M. U., Bravo-Cordero, J. J., Torramade-Moix, S., Escolar, G., Jerez-Dolz, D., Lev, E. I. & Badimon, J. J., 2022, In: Platelets. 33, 2, p. 312-319 8 p.Research output: Contribution to journal › Article › peer-review
-
Empagliflozin improves quality of life in nondiabetic HFrEF patients. Sub-analysis of the EMPATROPISM trial
Requena-Ibáñez, J. A., Santos-Gallego, C. G., Rodriguez-Cordero, A., Vargas-Delgado, A. P. & Badimón, J. J., Feb 2022, In: Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 16, 2, 102417.Research output: Contribution to journal › Article › peer-review
11 Scopus citations -
Factor XI/XIa Inhibition: The Arsenal in Development for a New Therapeutic Target in Cardio- and Cerebrovascular Disease
Badimon, J. J., Escolar, G. & Zafar, M. U., Dec 2022, In: Journal of Cardiovascular Development and Disease. 9, 12, 437.Research output: Contribution to journal › Review article › peer-review
Open Access -
HDL: un nuevo biomarcador para la insuficiencia cardiaca
Translated title of the contribution :High-density lipoprotein cholesterol: a new marker in heart failure Research output: Contribution to journal › Article › peer-review
Press / Media
-
EMPA-TROPISM: Empagliflozin improves LV remodeling in patients with heart failure
20/01/21
1 item of Media coverage
Press/Media
-
Empagliflozin LV remodeling not reliant on glucose lowering
25/11/20
1 item of Media coverage
Press/Media
-
Empagliflozin Also Beneficial in Heart-Failure Patients Without Diabetes
Carlos Santos-Gallego & Juan Badimon
25/11/20
1 item of Media coverage
Press/Media
-
Empagliflozin, Can Treat And Reverse Heart Failure In Both Diabetes
Carlos Santos-Gallego & Juan Badimon
16/11/20 → 19/11/20
7 items of Media coverage
Press/Media
-
Empagliflozin Improves Cardiac Function, Exercise Capacity in Nondiabetic HFrEF
16/11/20
1 item of Media coverage
Press/Media